Contineum Therapeutics, Inc. Class A Common Stock

What is Contineum Therapeutics, Inc. Class A Common Stock (CTNM) stock price today?

As of Dec 15, 2025, 6:08 PM UTC, Contineum Therapeutics, Inc. Class A Common Stock (CTNM) stock is trading at $11.61. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date CTNM stock quotes for informed trading decisions.

What is Contineum Therapeutics, Inc. Class A Common Stock's market capitalization?

Contineum Therapeutics, Inc. Class A Common Stock (CTNM) has a market capitalization of approximately $338.8M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Contineum Therapeutics, Inc. Class A Common Stock's size relative to other companies in the USD market. The market cap figure updates automatically as the CTNM stock price changes.

What is the 52-week range for Contineum Therapeutics, Inc. Class A Common Stock stock?

Contineum Therapeutics, Inc. Class A Common Stock (CTNM) stock has traded in a 52-week range of $3.35 — $15.25. The 52-week range shows the highest and lowest prices at which CTNM traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Contineum Therapeutics, Inc. Class A Common Stock stock price to this range provides context for recent price action.

How much trading volume does Contineum Therapeutics, Inc. Class A Common Stock stock have?

Contineum Therapeutics, Inc. Class A Common Stock (CTNM) stock recently traded approximately 120K shares. Trading volume indicates market liquidity and investor interest in CTNM. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Contineum Therapeutics, Inc. Class A Common Stock stock.

Does Contineum Therapeutics, Inc. Class A Common Stock pay dividends to shareholders?

Yes, Contineum Therapeutics, Inc. Class A Common Stock (CTNM) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Contineum Therapeutics, Inc. Class A Common Stock stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Contineum Therapeutics, Inc. Class A Common Stock's intraday price range?

Today, Contineum Therapeutics, Inc. Class A Common Stock (CTNM) stock has traded in a range of $11.58 — $11.85. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring CTNM's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Contineum Therapeutics, Inc. Class A Common Stock stock data?

AlphaPilot sources real-time CTNM stock quotes, fundamental financial data, and historical price charts for Contineum Therapeutics, Inc. Class A Common Stock from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Contineum Therapeutics, Inc. Class A Common Stock stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of CTNM stock performance.